-
MedPage Today: Early Marker Found for Long-Term Gout Flare Potential
-
Rheumatology Advisor: Genetic Predisposition Amplifies Gout Risk in Association With Ultra-Processed Food Consumption
-
Rheumatology Advisor: Patients With Gout Face an Elevated Risk for Cardiovascular Mortality
-
HCP Live: Gaps in Practice Appear in Primary Healthcare Physicians Treating Gout
-
Rheumatology Advisor: Low Febuxostat Dose Appropriate for Patients With Gout and Impaired Renal Function
-
HCP Live: Gout Linked to a Significantly Higher Likelihood of Migraines
-
Korea Biomedical Review: LG Chem set to launch European clinical trial of gout drug tigulixostat
-
Business Wire: Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
-
Healio: ‘Gout may not be managed properly’: Premature mortality in gout remains elevated in US, UK
-
HCP Live: Urate-Lowering Therapy Could Also Lower Blood Pressure in Gout Patients
-
HCP Live: Treating Gout Flares with Opioid Therapy Links to Chronic Opioid Use
-
HCP Live: Gout Flares: Associations with Initiation, Escalation of Urate-Lowering Therapy
-
Doc Wire News: Changes in Lipidome of Hyperuricemic and Gout Patients Has Significant Effect on Lipid Metabolism
-
Healio: Case study indicates potential link between chronic tophaceous gout and hypercalcemia
-
HCP Live: Urate-Lowering Therapy Could Also Lower Blood Pressure in Gout Patients
-
MedPage Today: Novel Gout Drug Aces Mid-Stage Tests
-
HCP Live: SEL-212 Shows Significant Response Rates, sUA Reductions in Patients with Gout
-
HCP Live: Gout’s Prevalence Among Vulnerable Populations: A Deeper Look into the Painful Disease
-
HCP Live: DASH Diet Significantly Improves Serum Urate Levels Among Patients with Hyperuricemia
-
Renal and Urology News: SGLT2 Inhibitors May Lower Risk for Recurrent Gout Flares, Early Mortality
-
Medical Professionals Reference: Ilaris Approval Expanded to Include Treatment of Gout Flares
-
HCP Live: Patients with Gout More Likely to Experience Stroke, Heart Failure